Order results by:
| Issue | Title | |
| Vol 15, No 4 (2023) | Pharmacokinetic parameters, safety and drug-drug interactions of mirtazapine and tizanidine, combined in the new original drug Dorsumio® | Abstract similar documents |
| A. S. Goncharov, A. V. Grigoriev, A. A. Globenko, I. S. Goncharov, K. A. Muratov, D. V. Yaroshenko, A. A. Sidorova, A. V. Kapashin, O. V. Kovchan, A. I. Bashkatova, M. A. Pasko | ||
| "... in the pharmacokinetics of the individual drugs. There was no significant reciprocal effect of mirtazapine and tizanidine ..." | ||
| Vol 12, No 2 (2020) | The history of mianserin and mirtazapine: study of their neurochemical activity and determination of their position in the classification of antidepressants | Abstract similar documents |
| D. S. Danilov, Yu. G. Tyulpin, V. D. Morozova | ||
| "... and mirtazapine. The concept of the development of the antidepressant effect of these drugs, by stimulating ..." | ||
| Vol 10, No 4 (2018) | Chemoreactome analysis of tolperisone, tizanidine, and baclofen molecules: anticholinergic, antispasmodic, and analgesic mechanisms of action | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, L. V. Stakhovskaya, V. A. Semenov | ||
| "... with tizanidine and baclofen, allowing the pharmacological action of each of the molecules to be specified ..." | ||
| Vol 6, No 3 (2014) | Myofascial pain: from Virchow's to our days | Abstract similar documents |
| I. V. Egorov | ||
| Vol 12, No 1 (2020) | Comparative efficacy and tolerance of centrally acting muscle relaxants in elderly patients with nonspecific musculoskeletal pain | Abstract similar documents |
| R. V. Gorenkov, M. N. Dadasheva, I. A. Zolotovskaya, V. A. Kruglov | ||
| "... (calmyrex) versus tizanidine and baclofen in the therapy of acute nonspecific musculoskeletal pain (NSMSP ..." | ||
| Vol 3, No 3 (2011) | Treatment for poststroke spasticity, the use of mydocalm | Abstract similar documents |
| V. A. Parfenov | ||
| "... functions. Baclofen (baklosan), tizanidine (sirdalud), and tolperisone hydrochloride (mydocalm) may be used ..." | ||
| Vol 13, No 3 (2021) | Sleep disorders in acute and chronic pain | Abstract similar documents |
| M. G. Poluektov, A. O. Golovatyuk | ||
| "... ) and pharmacological approaches are used in insomnia treatment. Some medications (amitriptyline, mirtazapine, trazodone ..." | ||
| Vol 12, No 1 (2020) | The fixed combination of diclofenac and orphenadrine in the treatment of acute pain syndromes | Abstract similar documents |
| E. A. Ushkalova, S. K. Zyryanov, K. E. Zatolochina | ||
| "... analgesic properties, for example tizanidine and orphenadrine, would be appropriate for use as part ..." | ||
| Vol 12, No 2 (2020) | Pharmacogenetics of the safety of phenazepam in alcohol withdrawal syndrome: haplotype and combinatorial analyses of polymorphic variants in the pharmacokinetic factor genes | Abstract similar documents |
| D. V. Ivashchenko, O. V. Tereshchenko, I. I. Temirbulatov, K. A. Akmalova, E. A. Grishina, M. S. Zastrozhin, L. M. Savchenko, E. A. Bryun, D. A. Sychev | ||
| Vol 15, No 4 (2023) | Evaluation of pharmacokinetic parameters, safety and tolerability of single and multiple doses of Vespireit®: results of phase I clinical trial. | Abstract similar documents |
| O. D. Ostroumova, M. L. Maksimov, M. V. Zamergrad, V. A. Parfenov, E. K. Zaharova, A. L. Vladykin, A. A. Globenko, A. V. Kapashin, K. A. Ishchenko | ||
| "... Objective: to evaluate the pharmacokinetic parameters, safety and tolerability of Vespireit® (INN ..." | ||
| Vol 8, No 4 (2016) | MexiB 6 AS A RESULT OF FORTIFICATION OF ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE WITH MAGNESIUM AND PYRIDOXINE: PROTEOME EFFECTS | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, A. G. Kalacheva, V. A. Semenov, K. V. Rudakov | ||
| Vol 9, No 3 (2017) | Clinical results of and prospects for the use of controlled-release antiepileptic drugs: a new once-daily levetiracetam formulation | Abstract similar documents |
| P. N. Vlasov | ||
| "... to trough blood concentrations. According to this pharmacokinetic profile, there may be both adverse events ..." | ||
| Vol 16, No 2 (2024) | Selection of NSAIDs for rational pharmacotherapy of chronic musculoskeletal pain: a clinical pharmacologist's perspective | Abstract similar documents |
| O. I. Butranova, S. K. Zyryanov | ||
| "... in their pharmacodynamic and pharmacokinetic parameters and correspondingly to differences in their efficacy and safety ..." | ||
| Vol 9, No 1S (2017): SPECIAL ISSUE: EPILEPSY | The efficacy and safety of valproic acid medications with controlled active ingredient release in adults in real clinical practice from the position of pharmacokinetic and pharmacogenetic approaches | Abstract similar documents |
| P. N. Vlasov, N. V. Orekhova, M. V. Antonyuk, N. V. Filatova, N. A. Schnaider, D. V. Dmitrenko, S. N. Zobova, I. E. Poverennova, A. V. Yakunina, V. A. Kalinin, S. K. Zyryanov, I. F. Tishchenkova | ||
| Vol 17, No 1 (2025) | Tenoxicam. Pharmacological and clinical profile | Abstract similar documents |
| V. V. Afanasyev, D. A. Iskra | ||
| "... The review contains information on the pharmacodynamics, pharmacokinetics and clinical ..." | ||
| Vol 9, No 1S (2017): SPECIAL ISSUE: EPILEPSY | Rationale for mono- versus polytherapy with antiepileptic drugs for patients with epilepsy | Abstract similar documents |
| L. V. Lipatova, T. V. Kapustina | ||
| "... of action, pharmacokinetic and pharmacodynamic properties, efficacy, and safety profile of AEDs, disease ..." | ||
| Vol 12, No 4 (2020) | The use of cannabinoids in epilepsy as an example: medical, social, and legal aspects | Abstract similar documents |
| R. G. Akzhigitov, K. I. Pochigayeva, F. K. Rider, A. M. Teplyshova, S. I. Dedayev, I. A. Shpak, E. V. Pashnin, A. B. Gekht | ||
| "... the mechanisms of action of cannabinoids, the characteristics of their pharmacokinetics and pharmacodynamics ..." | ||
| Vol 8, No 2 (2016) | Effects of etifoxine: Chemoreactome simulation | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, L. E. Fedotova, A. N. Gromov | ||
| "... ) negative side effects and 5) pharmacokinetic parameters. Conclusion. The findings are consistent ..." | ||
| Vol 16, No 3 (2024) | Epilepsy and pregnancy | Abstract PDF (Eng) similar documents |
| P. N. Vlasov, A. M. Azhigova, E. B. Efimkova, V. A. Petrukhin | ||
| "... in the pharmacokinetics of antiepileptic drugs during pregnancy are presented. A classification of antiepileptic drugs ..." | ||
| Vol 13, No 2 (2021) | Chemoreactom analysis of cytidyldiphosphocholine indicates synergistic combinations of neuroprotective agents | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, L. A. Mayorova, T. R. Grishina, L. E. Fedotova, A. N. Gromov, I. S. Sardaryan | ||
| "... , pharmacokinetic and pharmacodynamic parameters, the effect on the metabolome and proteome, the survival of neurons ..." | ||
| Vol 10, No 4 (2018) | Use of valproate and carbamazepine in the therapy of epilepsy (guidelines for the practitioner) | Abstract similar documents |
| P. N. Vlasov | ||
| "... , the presence of a variety of dosage forms, and favorable pharmacokinetic and pharmacodynamic profiles still ..." | ||
| Vol 7, No 4 (2015) | Some aspects of treatment for cognitive impairments. Cyticolin: pharmacological characteristics, possible benefits, aspects of use | Abstract similar documents |
| N. V. Trofimova, I. S. Preobrazhenskaya | ||
| "... The paper reviews the data available in the literature on the pharmacokinetic and pharmacodynamic ..." | ||
| No 1S (2016): | Partial epilepsies: Choice of antiepileptic drugs in adults in the outpatient setting | Abstract similar documents |
| P. N. Vlasov | ||
| "... chrono or Depakine chronosphere and its intravenous formulation, favorable pharmacokinetic ..." | ||
| Vol 4, No 1 (2012) | Generalized epilepsies: current conceptions and therapeutic approaches | Abstract similar documents |
| L R Zenkov | ||
| "... . The paper considers the basic pharmacokinetic and pharmacodynamics properties of the drugs for the treatment ..." | ||
| Vol 7, No 1S (2015): Special issue "Epilepsy" | Use of valproates in women of childbearing age and pregnant women with epilepsy | Abstract similar documents |
| P. N. Vlasov | ||
| "... forms, including long-acting or intravenous formulatons, and favorable pharmacokinetic ..." | ||
| Vol 7, No 1 (2015) | Antidepressants are selective serotonin neuronal reuptake inhibitors: 40-year history | Abstract similar documents |
| D. S. Danilov | ||
| "... ; the likelihood of an unfavorable pharmacokinetic interaction with other drugs; the half-life of elimination ..." | ||
| Vol 12, No 5 (2020) | The polymorphic variants DRD2 rs1800497 and ABCB1 3435C>T are associated with antipsychotic safety parameters in adolescents with an acute psychotic episode: the results of a pilot study | Abstract PDF (Eng) similar documents |
| D. V. Ivashchenko, S. Z. Khoang, M. Kh. Tazagulova, B. V. Makhmudova, N. I. Buromskaya, P. V. Shimanov, R. V. Deitch, I. V. Dorina, M. I. Nastovich, K. A. Akmalova, A. A. Kachanova, E. A. Grishina, L. M. Savchenko, Yu. S. Shevchenko, D. A. Sychev | ||
| "... of a drug. The genes of pharmacokinetic factors have been shown to be of high prognostic value ..." | ||
| 1 - 27 of 27 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
